On 14–15 September 2017, Astana (Kazakhstan) will host a big Eurasia-wide event called International Scientific and Practical Conference Today's infections in Central Asia: management of infectious diseases as part of primary health care. Leading experts will discuss burning issues concerning infectious diseases, such as influenza, ARVI, pneumonia; viral hepatitis; parasitic diseases; HIV/AIDS; preventive vaccination and treatment.
In anticipation of the epidemic flu season, a special focus will be on influenza and ARVI prevention. On 15 September at 10:40–11:40, a symposium on Approaches to influenza and ARVI prevention in different social groups will be held as part of the conference. The symposium will be moderated by Yu. Lobzin, chief paediatrician for infectious diseases, Russia's Ministry of Health, M. Smagul, Head of epidemiological monitoring of the infectious and parasitic diseases department, Scientific and Practical Centre of Sanitary and Epidemiological Expertise and Monitoring of Kazakhstan, and V. Volzhanin, honoured doctor of the Russian Federation, PhD, associate professor, academic secretary at the Children’s Scientific and Clinical Centre of Infectious Diseases of the Federal Biomedical Agency of Russia.
The symposium's scientific programme comprises the following reports:
- M. Smagul “Epidemiological situation on influenza and ARVI incidence in the Republic of Kazakhstan” (Almaty, Kazakhstan).
- Yu. Lobzin, V. Volzhanin “Effect of influenza vaccination on influenza rates across different social groups. Russian Experience” (St Petersburg, Russia).
- S. Kharit, Head of the immunoprophylaxis department of the Research Institute for Paediatric Infections of the Federal Biomedical Agency of Russia “Application of polymer subunit influenza vaccines in healthy children and ill children” (St Petersburg, Russia).
- S. Amireev, holder of post-doctoral degree in medicine, professor, epidemiologist, academician of the Academy of Sciences of Clinical and Fundamental Medicine of the Republic of Kazakhstan “Comparative study on the application of influenza vaccines in adults in the Republic of Kazakhstan” (Almaty, Kazakhstan).
Another symposium called Preventive vaccination: results and prospects will be held on 15 September at 15:10–16:40 and chaired by S. Amireev and N. Azimbaeva. M. Kostinov, holder of post-doctoral degree in medicine, professor, Head of Laboratory of Preventive Vaccination and Immunotherapy, Mechnikov Research Institute of Vaccines and Sera, will deliver a report “Influenza preventive vaccination in pregnant women in Russia. Transplacental post-vaccination immunity to influenza virus in newborns.”
NPO Petrovax Pharm, a Russian biopharmaceutical company, provides support for academic and educational initiatives to promote preventive vaccination. Petrovax Pharm is also the main sponsor of the International Scientific and Practical Conference Today's infections in Central Asia: management of infectious diseases as part of primary health care.
Petrovax Pharm has been supplying medicines to Kazakhstan for over a decade now, and they are widely used in medical practice throughout the country, having earned the trust of both the doctors and consumers. Successful vaccine application in Kazakhstan contributes to growing supplies to this country and annual increase in sales of Polyoxidonium®, an original medicine that acts as an immunomodulator, antioxidant and detoxifier. Since 2016, Petrovax Pharm has been supplying Grippol® Plus anti-influenza vaccine to the country satisfying the basic vaccination needs of Kazakhstan's people. In August 2017, Petrovax Pharm exported over 2 m doses of Grippol® Plus anti-influenza vaccine to Kazakhstan for the 2017–2018 epidemic flu season.
Click for further details